Your browser doesn't support javascript.
loading
Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia.
Sasaki, Koji; Kantarjian, Hagop; Wierda, William; Ravandi-Kashani, Farhad; Jorgensen, Jeffrey; Wang, Sa A; Khoury, Joseph; Daver, Naval; Burger, Jan; Di Nardo, Courtney D; Jain, Nitin; Short, Nicholas J; Estrov Md, Zeev; Konopleva Md PhD, Marina; Ohanian DO, Maro; Garcia-Manero, Guillermo; Kadia, Tapan; Alvarado-Valero, Yesid; Yilmaz, Musa; Pierce, Sherry; Garris, Rebecca; Ingram, April; Cortes, Jorge; OʼBrien, Susan; Jabbour, Elias.
Afiliação
  • Sasaki K; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Wierda W; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi-Kashani F; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Jorgensen J; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang SA; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Khoury J; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver N; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Burger J; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Di Nardo CD; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Jain N; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Short NJ; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Estrov Md Z; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva Md PhD M; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Ohanian DO M; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia-Manero G; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia T; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Alvarado-Valero Y; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Yilmaz M; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Pierce S; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Garris R; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Ingram A; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Cortes J; Georgia Cancer Center, Augusta, Georgia, USA.
  • OʼBrien S; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California, USA.
  • Jabbour E; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 95(7): 734-739, 2020 07.
Article em En | MEDLINE | ID: mdl-32170867
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vincristina / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vincristina / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article